… Although much of this research has focused on papillary thyroid cancer or other cancers,
several kinase inhibitors have been evaluated for activity in MTC, and 2, vandetanib and …

… differentiated thyroid cancer (DTC), medullary thyroid carcinoma (MTC) and anaplastic thyroid
cancer (ATC). Newer developments apply precision medicine in thyroid cancer patients to …

… and medical management of individual types of thyroid cancer. This organization is important,
because it helps emphasize that each thyroid cancer … to the management of unique thyroid …

… fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a
… tion of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J …

… However, in the setting of these advances, disparities exist in the diagnosis and management
of thyroid cancer. As new management options are becoming available for thyroid cancer, …

… and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97: 418-428 …
term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. …

… document is the management of thyroid cancer, rather than investigation of thyroid nodules.
… , medullary thyroid cancer anaplastic thyroid cancer, thyroid lymphoma and other very rare …

… the optimum management of patients with well differentiated thyroid carcinoma because of
… The aim of the present study was not to determine optimum management of thyroid cancer, …

… She also participates in clinical trials for the evaluation of multikinase inhibitor therapies
in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules. …

… diagnosis and treatment of thyroid cancer, with recommendations from the American Thyroid
Association regarding thyroid nodules and differentiated thyroid cancer. Recently approved …